About
FAQ
Reports
Contact Us
Works
Groups
People
Publications
Publishers
In Press
Advanced
2 Results for:
created: (01/2018 to 01/2018)
People
Slovin
Stein
Groups
Department of Medicine
(2)
Hematologic Malignancies, Division of
(2)
Adult Leukemia
(1)
Center for Hematologic Malignancies
(1)
Genitourinary Oncology Service
(1)
Solid Tumor Oncology Division
(1)
"Future Medicine"
Formats
Journal Article (2)
Groups
Department of Medicine (2)
Hematologic Malignancies, Division of (2)
Adult Leukemia (1)
Center for Hematologic Malignancies (1)
Genitourinary Oncology Service (1)
Solid Tumor Oncology Division (1)
People
Eytan Stein (1)
Susan Slovin (1)
Years
2018 (1)
2017 (1)
Publications
Biomarkers in Medicine (1)
Future Oncology (1)
Publishers
Future Medicine (2)
Results (2)
Export to EndNote / Excel
Show:
10
20
50
100
250
500
1000
2000
Sort By:
Author
Title
Year
Relevance
Created
Order:
Ascending
Descending
Style:
Nature
NLM
NIH-PMCID
Citation style sort is year ascending, and then by author or title. Author ascending is default.
Enasidenib, a targeted inhibitor of mutant IDH2 proteins for treatment of relapsed or refractory acute myeloid leukemia
Journal Article
Stein, E. M.
Future Oncology
(2018)
Fulltext@MSK
|
Save
The need for immune biomarkers for treatment prognosis and response in genitourinary malignancies
Journal Article
Slovin, S. F.
Biomarkers in Medicine
(2017)
Fulltext@MSK
|
Save